Skip to main content
. 2022 Mar 8;12:3745. doi: 10.1038/s41598-022-07466-z

Figure 3.

Figure 3

Comparing of multivariate Cox regression analysis for endpoints in patients with atrial fibrillation receiving rivaroxaban with concomitant AADs.